Literature DB >> 6125677

A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.

J C Woods, A I Spriggs, H Harris, J O McGee.   

Abstract

The Ca1 antibody has been used in an immunocytochemical procedure on smears of cells recovered from 50 effusions from the pericardial, peritoneal, and pleural cavities. In 25 samples containing malignant cells, as assessed by conventional morphological criteria, this antibody distinguished malignant from non-malignant cells in 21 samples. The exceptions were 2 lymphomas and 2 out of 6 carcinomas of the lung. The Ca1 antibody also reacted with malignant mesothelial cells from 2 mesotheliomas, but not with reactive mesothelial cells. This antibody thus provides a new method for the identification of malignant cells in pericardial, peritoneal, and pleural effusions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125677     DOI: 10.1016/s0140-6736(82)90598-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy.

Authors:  A K Ghosh; A I Spriggs; M Charnock
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

2.  Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.

Authors:  A Donna; P G Betta; F Robutti
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

3.  Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.

Authors:  A K Ghosh; D Y Mason; A I Spriggs
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

4.  Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.

Authors:  A K Ghosh; A I Spriggs; J Taylor-Papadimitriou; D Y Mason
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

5.  Demonstration of carcinoembryonic antigen in bone marrow from patients with carcinoma.

Authors:  A Gray; R Downing; R Hill; R W Payne; C W Windsor
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

6.  Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.

Authors:  F J Paradinas; G Boxer; K D Bagshawe
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

7.  The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).

Authors:  C A Szpak; W W Johnston; V Roggli; J Kolbeck; S C Lottich; R Vollmer; A Thor; J Schlom
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

8.  [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy].

Authors:  A Neubauer; U Thalmann; R Musch; H Grosser; R Loddenkemper; D Huhn
Journal:  Klin Wochenschr       Date:  1987-05-04

9.  CD 34 immunotyping of blasts in myelodysplasia.

Authors:  J Oertel; B Oertel; J Beyer; D Huhn
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

10.  Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.

Authors:  S Singer; M M Boddington; E A Hudson
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.